Female gender is a risk factor for torsades de pointes in an in vitro animal model

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 2, 1999, Pages 287-294

  Liu, Xiao Ke ^a   Wang, Wenxiu ^a   Ebert, Steven N ^a   Franz, Michael R ^b   Katchman, Alexander ^a   Woosley, Raymond L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

4 Aminopyridine; Cycle length; Gender; QT; Torsades de pointes

Indexed keywords

4 AMINOPYRIDINE; MAGNESIUM; POTASSIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DISEASE PREDISPOSITION; FEMALE; HEART ARRHYTHMIA; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM TRANSPORT; PRIORITY JOURNAL; QT INTERVAL; RABBIT; RISK FACTOR; SEX DIFFERENCE; TORSADE DES POINTES;

4-AMINOPYRIDINE; ANIMALS; ELECTROCARDIOGRAPHY; FEMALE; MALE; POTASSIUM CHANNEL BLOCKERS; RABBITS; SEX FACTORS; TORSADES DE POINTES;

EID: 0032787944     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199908000-00015     Document Type: Article

References (40)

1. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7.
2. Kawasaki R, Machado C, Reinoehl J, et al. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol 1995;6:1032-8.
3. Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsades de pointes with d,l-sotalol. Circulation 1996;94:2535-41.
4. Liu XK, Wang WX, Woosley RL. Gender affects the rate-dependent prolongation of cardiac repolarization by d-sotalol [Abstract]. Clin Pharmacol Ther 1997;61:229.
5. Drici M-D, Burklow TR, Haridasse V, et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996;94:1472-5.
6. Chennareddy SB, Siddique M, Karim MY, et al. Erythromycin-induced polymorphous ventricular tachycardia with normal QT interval. Am Heart J 1996;132:691-4.
7. Carlsson L, Almgren O, Duker G. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J Cardiovasc Pharmacol 1990;16:276-85.
8. Weissenburger J, Davy JM, Chezalviel F. Experimental models of torsades de pointes. Fund Clin Pharmacol 1993;7:29-38.
9. Vos MA, Verduyn SC, Gorgels AP, et al. Reproducible induction of early afterdepolarizations and torsades de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91:864-72.
10. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-52.
11. Browne KF, Zipes DP, Heger JJ, et al. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982; 50:1099-103.
12. Woosley RL, Sale M. QT interval: a measure of drug action. Am J Cardiol 1993;72:36B-43B.
13. Pinney SP, Koller BS, Franz MR, et al. Terfenadine increases the QT interval in isolated guinea pig heart. J Cardiovasc Pharmacol 1995;25:30-4.
14. Giles WR, Imaizumi Y. Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol 1988;405:123-45.
15. Daleau P, Khalifa M, Turgeon J. Effects of cadmium and nisoldipine on the delayed rectifier potassium current in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1997;281:826-33.
16. Agus ZS, Dukes ID, Morad M. Divalent cations modulate the transient outward current in rat ventricular myocytes. Am J Physiol 1991;261:C310-8.
17. Varro A, Lathrop DA, Hester SB, et al. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol 1993;88:93-102.
18. Kr, by flecainide and E-4031 in cat ventricular myocytes. Circulation 1990;82:289-93.
19. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992;262:809-17.
20. Clay JR, Ogbaghebriel A, Paquette T, et al. A quantitative description of the E-4031-sensitive repolarization current in rabbit ventricular myocytes. Biophys J 1995;69:1830-7.
21. Van Bogaert PP, Snyders DJ. Effects of 4-aminopyridine on inward rectifying and pacemaker currents of cardiac Purkinje fibres. Pflugers Arch 1982;394:230-8.
22. Kukushkin NI, Gainullin RZ, Sosunov EA. Transient outward current and rate dependence of action potential duration in rabbit cardiac ventricular muscle. Pflugers Arch 1983;399:87-92.
23. Nabauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:386-94.
24. Stevenson WG. Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol 1995;10:274-81.
25. Kumar A, Bhandari AK, Rahimtoola SH. Torsades de pointes and marked QT prolongation in association with hypothyroidism. Ann Intern Med 1987;106:712-3.
26. Shimoni Y, Severson D, Giles WR. Thyroid status and diabetes modulate regional differences in potassium currents in rat ventricle. J Physiol (Lond) 1995;488:673-88.
27. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 1994;269:66-74.
28. Crumb WJ, Wible B, Arnold DJ, et al. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 1995;47:181-90.
29. Berul CI, Morad M. Regulation of potassium channels by nonsedating antihistamines. Circulation 1995;91:2220-5.
30. Berger F, Borchard U, Hafner D. Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres. Naunyn Schmiedebergs Arch Pharmacol 1989;339:638-46.
31. Le Grand B, Marty A, Colpaert FC, et al. Ketanserin inhibits the transient outward current in rabbit ventricular myocytes. J Cardiovasc Pharmacol 1995;25:341-4.
32. Coraboeuf E, Deroubaix E, Escande D, et al. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. Cardiovasc Res 1988; 22:375-84.
33. Kaab S, Nuss HB, Chiamvimonvat N, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996;78:262-73.
34. Liu X-K, Katchman A, Drici MD, et al. Gender difference in the cycle length dependent QT and outward potassium currents. J Pharmacol Exp Ther 1998;285:672-9.
35. Asano Y, Davidenko JM, Baxter WT, et al. Optical mapping of drug-induced polymorphic arrhythmias and torsades de pointes in the isolated rabbit heart. J Am Coll Cardiol 1997;29:831-42.
36. Denker S, Lehmann MH, Mahmud R, et al. Divergence between refractoriness of His-Purkinje system and ventricular muscle with abrupt changes in cycle length. Circulation 1983;68:1212-21.
37. Janse MJ, Dam RT van. Effect of abrupt changes in heart rate on refractory periods of ventricular myocardium and specialized conducting system in dog's heart. Br Heart J 1971;33:148.
38. Denker S, Lehmann R, Mahmud R, et al. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 1984;53:508-15.
39. Burashnikov A, Antzelevitch C. Mechanism of acceleration induced early afterdepolarization activity and action potential prolongation in tissues isolated from the M region of the canine ventricle. PACE Pacing Clin Electrophysiol 1996;19:645.
40. Drici MD, Knollmann B, Wang W, Woosley RL. Cardiac actions of erythromycin: influence of gender. JAMA 1998;28:1774-6.